The Benchmark Company Lowers the Harte-Hanks (HHS) Bar

The Benchmark Company has updated its analytical coverage of Harte-Hanks, Inc. (NYSE: HHS), In a new report posted this morning, the research firm notes that the fourth quarter’s (2009) results were mixed, and that challenges remain despite the improved company outlook.

The report states “In view of management’s outlook and prospects of a slow economic recovery, we have trimmed our 2010 estimates… We forecast total revenue may decline 3% y/y … EBITDA could fall 2% y/y to $115 million, leading to EPS of $0.82, down from $0.85…”

Banchmark currently considers of Harte-Hanks, Inc. a ‘hold’, yet considers its sector – advertising and marketing services – an ‘overweight’. There is no price target offered by The Benchmark Company.